Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

QLT settles Eligard patent dispute; pay-out is $157.5mm

Executive Summary

QLT Inc. (ophthalmology, urology, and dermatology treatments) and its QLT USA subsidiary (formerly Atrix Laboratories) have reached an agreement with TAP Pharmaceutical Products, Takeda Chemical, and Wako Pure Chemical regarding potential patent infringement.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies